GROUP 3 PULMONARY HYPERTENSION

Clinical trials for GROUP 3 PULMONARY HYPERTENSION explained in plain language.

Never miss a new study

Get alerted when new GROUP 3 PULMONARY HYPERTENSION trials appear

Sign up with your email to follow new studies for GROUP 3 PULMONARY HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill aims to ease strain on scarred lungs

Disease control Recruiting now

This study is testing whether a new daily pill called mirivadelgat can help adults with pulmonary hypertension associated with interstitial lung disease (PH-ILD). Researchers want to see if the drug improves blood flow in the lungs and helps with symptoms like shortness of breath…

Matched conditions: GROUP 3 PULMONARY HYPERTENSION

Phase: PHASE2 • Sponsor: Foresee Pharmaceuticals Co., Ltd. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

GROUP 3 PULMONARY HYPERTENSION

Get alerted when new GROUP 3 PULMONARY HYPERTENSION trials appear

New pill aims to ease strain on scarred lungs